NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research

        • Research Overview
        • Clinical Research Facility
        • 15 Research Themes

        • Cancer
        • Cardiovascular Medicine
        • Digital Health from Hospital to Home
        • Gene and Cell Therapy
        • Genomic Medicine
        • Imaging
        • Inflammation across Tissues
        • Life-saving Vaccines
        • Metabolic Experimental Medicine
        • Modernising Medical Microbiology and Big Infection Diagnostics
        • Musculoskeletal
        • Preventive Neurology
        • Respiratory Medicine
        • Surgical Innovation, Technology and Evaluation
        • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events
Research Theme

Gene and Cell Therapy

You are here: Home > Research Overview > Gene and Cell Therapy > T cell therapies

T cell therapies

An important part of our work in this theme relates to the modification or editing of T cells. T cells are white blood cells that are an important part of the body’s immune system.  They detect and destroy abnormal cells, such as cancer cells. If your T-cells don’t work properly, abnormal cells can grow and multiply.

T cell receptor gene therapy for blood cancers

This research is finding ways to use T cells to create treatments for blood cancer.

Teams led by Professors Ronjon Chakraverty and Paresh Vyas have found a way to identify T cell receptors (TCRs) that react to blood cancer cells.

TCRs join onto particular proteins that can be found on the surface of blood cancer cell surface. This prompts the immune system to fight against that cell.

If we can make T-cells that ‘switch on’ these TCRs, then the cells can be used as a treatment for several different kinds of blood cancer. Unlike other T-cell therapies, these treatments would not need to be manufactured to match the cells of each individual patient: they would work for lots of different people, known as an ‘off-the-shelf’ therapy.

In partnership with Oxford Biomedica we are designing a way to test how T cells might switch on TCRs in the correct way. We hope that this work will lead to clinical trials to test these TCRs in patients for the first time.

Gene editing of T cells to treat multiple sclerosis

Some of our research is finding out how to edit genes to provide protection against disease.

From looking at information about the genomes of multiple people, a team led by Dr Calliope Dendrou has been able to identify a variant of a normal gene that protects against autoimmune diseases such as multiple sclerosis (MS). This is a variant in the TYK2 gene.

Professor Adam Wilkinson and Professor James Davies are researching how we can edit the TYK2 gene in blood stem cells to make sure it includes this protective variant. The stem cells could then be given as a transplant into people with MS, and hopefully slow the disease or stop it getting worse.

We are working with the NIHR Sheffield BRC to obtain clinical samples from MS patients to test whether or not this gene editing approach works. We will work with MS patient groups and carry out an early phase trial in people with ‘high risk’ MS.

Gene and Cell Therapy

  • Gene and Cell Therapy
  • Eye therapies
  • T cell therapies
  • Contacts
  • Videos
  • News

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre